We are thrilled to be in Rome, Italy, next week to deliver 11 presentations at the European Society of Gene and Cell Therapy 31st Annual Meeting. The two oral and nine poster presentations highlight exciting progress in the #AskBio clinical and pre-clinical pipeline and advancements in our manufacturing technologies. Alongside recent clinical program milestones, the presentations demonstrate our commitment to advancing our end-to-end capabilities and our goal of delivering breakthrough therapies. For Medical Media – Read our press release here: https://lnkd.in/esFnVFcs #GeneTherapy #ESGCT2024
Asklepios BioPharmaceutical, Inc. (AskBio)
Biotechnology Research
Research Triangle Park, North Carolina 36,766 followers
Pioneering science to create transformative molecular medicines.
About us
Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, is a fully integrated gene therapy company dedicated to developing life-saving medicines and changing lives. The company maintains a portfolio of clinical programs across a range of neuromuscular, central nervous system, cardiovascular and metabolic disease indications with a clinical-stage pipeline that includes therapeutics for congestive heart failure, Huntington’s disease, limb-girdle muscular dystrophy, multiple system atrophy, Parkinson’s disease, and Pompe disease. AskBio’s gene therapy platform includes Pro10™, an industry-leading proprietary cell line manufacturing process, and an extensive capsid and promoter library. With global headquarters in Research Triangle Park, North Carolina, and European headquarters in Edinburgh, Scotland, the company has generated hundreds of proprietary capsids and promoters, several of which have entered pre-clinical and clinical testing. Learn more at askbio.com. Vision - Pioneering science to create transformative molecular medicines. Mission - Lead innovative science and drive clinical outcomes to transform people's lives. Values: • Be a Pioneer. We are not afraid of the impossible and to innovate to make gene therapies accessible to those in need. • Cultivate Collaboration. Strive to be the best teammate, actively listen, openly communicate, and embrace diverse points of view. • Embrace Responsibility. We are humbled by the enormity of our mission. We hold a relentless commitment to advance science and clinical outcomes for our patients, families, and caregivers. • Raise the Bar. Continuously drive improvements and efficiencies. Seek and provide constructive feedback. Have a bias for learning and action. • Act with Uncompromising Integrity. Be honest, transparent, and committed to doing what’s right in every situation. Make clear commitments and follow through.
- Website
-
http://www.askbio.com
External link for Asklepios BioPharmaceutical, Inc. (AskBio)
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Research Triangle Park, North Carolina
- Type
- Privately Held
- Founded
- 2001
- Specialties
- AAV, Adeno-Associated Virus, Gene Therapy, Rare Disease, AAV Manufacturing, Molecular Medicine, Nucleic Acid, Epigenome, and Doggybone DNA
Locations
Employees at Asklepios BioPharmaceutical, Inc. (AskBio)
-
Javier Garcia
General Partner and Founder of Columbus Venture Partners | Chairman of the Board of Viralgen | Secretary of Fundación Columbus | Tambor de Oro 2023
-
Gustavo Pesquin
-
Doug Schantz
Senior Vice President of Clinical Operations at Asklepios BioPharmaceutical, Inc. (AskBio)
-
Kira Mourão MBCS
Principal Machine Learning Scientist at Asklepios BioPharmaceutical, Inc. - (AskBio)
Updates
-
Today is World Mental Health Day, a day aimed at raising awareness about the importance of mental health and well-being in our lives, both professionally and personally. This year's theme is focused on prioritizing mental health in the workplace. The #AskBio employee assistance program and our flexible paid time off benefits help provide our employees with resources and tools to support their well-being. In addition to our more formal support, we encourage colleagues to form employee resource groups (ERGs), which add to our vibrant workplace culture by sponsoring events, providing information/education, and engaging in important conversations. On this important day, we’re proud to announce that we’re expanding our ERG network with our newest group, Minds of All Kinds. Co-founded by James Aykit and Amanda Carson. This ERG's mission is to empower those with neurodivergent, intellectual, and mental health differences by providing a safe space for learning, feedback, coaching, and education. Minds of All Kinds was created based on feedback from and the success of our Disability Pride event in July. We believe that when we can provide an inclusive environment for employees to reach their fullest potential, we are best suited to lead innovative science and drive clinical outcomes, which may transform people's lives. #MentalHealthMatters #WellbeingAtWork #WorldMentalHealthDay #Leadership #GeneTherapy
-
More than 50 #AskBio employees in the US and Europe recently participated in the Path to A Cure: Mission MSA Virtual Walk to support patients and families affected by multiple system atrophy (MSA). Our collective participation helped spread awareness to better understand and support people battling this complex disease. Patients are our North Star, and their resilience continues to be an inspiration for our mission of leading innovative science and driving clinical outcomes that may transform people's lives. Thanks to Mission MSA for providing us with this opportunity to come together as a team, across locations and time zones, and play a small role in helping them carry out their important work. #MissionMSA #PathToACure5K #RareDisease #WorldMSADay #GeneTherapy Alan Walsh ACA; Albana Alili Dalipi; Anand Thaker; Candace Summerford, Ph.D.; Cara Davis; Christopher Allen; Danielle Green; Deb Cole, CCDM; Ellen Kelly; Emily Slocum; Farah CHALI; Heather Caro, MBA BSN; Jane Williamson; Jason Krentz; Jen Barger Fleming, PhD DABT; Jenny Siferd, SPHR; Kara Witcoff; Mary Shaffer; Melissa Murrell; Minnal Gupta; Philip McNamara; Rosheen Caw; Susan Kratky; Tracy Dowling; Victor Stukat Gren; Kavonne Brooks; Gustavo Pesquin
-
The #AskBio team earlier this week wrapped up five days in Philadelphia, PA, at this year's International Congress of Parkinson's Disease and Movement Disorders. Thank you to the hundreds of attendees who visited our booth, attended our presentations, and took time to discuss with us the many exciting gene therapy developments that are unfolding at AskBio and across the Parkinson's disease landscape. A leading highlight was the presentation of our 36-month Phase 1b Parkinson’s investigational clinical trial data, which demonstrate encouraging current clinical stability of AB-1005 at 3 years. We look forward to continued follow up, which will help assess even longer term durability. We were also excited to present the design of our currently recruiting Phase 2 REGENERATE-PD trial. Fielding dozens of questions at our booth, we were energized by the significant interest in learning more about gene therapy. To learn more about these clinical trials, please visit clinicaltrials.gov (NCT 04167540 and NCT 06285643). We are excited about the potential of our advancing investigational gene therapy therapeutic options and by the meaningful impact our innovations could one day have for PD patients. Thanks to all the members of the AskBio team for their hard work over a busy and important few days. #Leadership #GeneTherapy #ParkinsonsDisease Adrian Kells, Akash P., Amber Van Laar, Chantal Letourneau, Christian Urrea, MD, Ellie (Yiqun) Hu), Juan Enrique Ortiz, M.D. BCMAS, Nisha Chhabria MD, FAAN, Steven Elmes, Waldy San Sebastian
-
We're excited to welcome Cristobal Passalacqua, MD who recently joined the #AskBio Global Clinical Development team as Vice President of Neuromuscular Clinical Development. Chris will be responsible for developing limb-girdle muscular dystrophy (LGMD) and Pompe studies as we work to advance these programs in the clinic. He describes himself as an optimist who believes there is always a solution or at least a positive way to deal with a situation. This mantra has supported Chris throughout his career in clinical development, where every day there are new challenges that may seem “too big” or “too complicated” to solve. #Leadership #GeneTherapy
-
We’re passionate about supporting the communities we serve and are excited to join Mission MSA’s Virtual Path to a Cure 5K. This is a special event for all of us at #AskBio...for a few reasons. First, as a company committed to exploring the potential of gene therapy in #MSA, we are grateful to have the opportunity to support an amazing organization and help raise awareness. Second, with our multiple locations in the US and Europe, and a large number of remote employees, we’re experts at coming together virtually to do important things, but it’s sometimes difficult for all of us to come together at one time as a global team and pursue fun and meaningful activities outside of work. #PathtoaCure5K gives us that chance. We’re looking forward to sharing photos next week of our colleagues as they put in their steps over the next few days and walk alongside every member of the MSA community. Melissa Murrell, Jen Barger Fleming, PhD DABT, Susan Kratky, Kara Witcoff, Meg Heim, Tara Swann, Victor Stukat Gren, Anand Mirchandani, Anand Thaker, Cristina Gude, Cara Davis, Ellen Kelly, Heather S., Albana Alili Dalipi, Danielle Green, Caitlin Taroski, Bishoy A., Sarah Smith, Katie Morris, Rosheen Caw, Vosha A., Stacy Ojala, Emily Slocum, Tracy Dowling, Kavonne Brooks, Heather Caro, MBA BSN, Trish Hamilton, Matt Fortier, Deb Cole, CCDM, Jenny Siferd, SPHR, Philip McNamara
Our Virtual Path to a Cure 5K is 24 HOURS AWAY, starting on World MSA Day! 🌍 Wherever you are in the world, you can participate on October 3rd, 4th, 5th, or 6th. 💜🏃♀️ Whether you’re running, walking, or supporting from afar, your involvement plays a critical role in raising awareness and fighting against MSA. Don’t forget to tag us in your photos and videos using #PathtoaCure5K, so we can feature you on our social media! It’s not too late to join—learn more here: https://lnkd.in/g4Dji9pc #MissionMSA #PathtoaCure #fundraiser #chicago #chicagoil #chicagoillinois #dallas #dallastx #dallastexas #raredisease #rarediseasefundraiser #WorldMSADay #register #5K #communitywalk #msa #multiplesystematrophy #msaawareness #event #raiseawareness #rarediseaseawareness #rarediseases #parkinsons #parkinsonsdisease #research #getinvolved #dallas #virtual #texas
-
It has been a productive few days for the #AskBio team in Philadelphia, PA at the International Congress of Parkinson's Disease and Movement Disorders. Highlights include the presentation of two abstracts outlining our REGENERATE-PD Phase 2 study design and the latest data cut of our Phase 1b data, as well as many meaningful interactions with advocacy partners and our REGENERATE-PD and MSA study investigators. We have two days remaining and look forward to continuing our important conversations about Parkinson's disease. Visit us at Booth 305. For more information about the REGENERATE-PD clinical trial, visit clinicaltrials.gov (NCT06285643), or visit askbio.com. #Leadership #GeneTherapy #ParkinsonsDisease Adrian Kells, Akash P., Amber Van Laar, Chantal Letourneau, Christian Urrea, MD, Ellie (Yiqun) Hu, Juan Enrique Ortiz, M.D. BCMAS, Nisha Chhabria MD, FAAN, Steven Elmes, Waldy San Sebastian
-
Today marks the 10th anniversary of Limb-Girdle Muscular Dystrophy Awareness Day. #AskBio proudly supports the people and families living with limb-girdle muscular dystrophy (LGMD), a group of diseases that cause weakness and wasting of the muscles in the arms and legs. Share your support for the community and learn more from the LGMD Awareness Foundation, Inc.: http://LGMD-Info.org #LGMDDay2024 #TogetherWeAreStronger #LGMDAwareness
-
Leaders from #AskBio and Shanghai-based Belief BioMed (BBM) earlier this week signed a collaboration agreement that will enable both companies to combine efforts and experience in #GeneTherapy technology to explore potential therapies for diseases that may be treatable using a liver-targeted approach. This strategic collaboration is an excellent example of how we work at AskBio. Collaborating with innovative, like-minded partners with complementary gene therapy expertise enables us to find the best way forward for our pipeline assets and bolster our efforts to advance new therapies for conditions with significant unmet need. #Leadership Jane Zheng, Philip Sin, Dr. Xiao Xiao, Tracy Dowling, Gustavo Pesquin
-
Limb-girdle muscular dystrophy (LGMD) is a term for a group of diseases that cause weakness and wasting of the muscles in the arms and legs. Brothers Brody and CJ began noticing LGMD symptoms in preschool, and as a progressive genetic disorder, the symptoms have become much worse in their teen years. Their parents Jodi and Craig remain hopeful as #AskBio and other companies are currently conducting trials with the goal of making a real difference for LGMD patients. AskBio is committed to leading innovative science and driving clinical outcomes. As LGMD Awareness Day approaches, we continue to think about the future for patients like Brody and CJ who are waiting for new options. #GeneTherapy #LGMDDay2024 #TogetherWeAreStronger #LGMDAwareness